i-STAT®

Increase efficiency, reduce costs & improve care

Abbott's i-STAT® 1 Wireless System is now available for use in hospitals, emergency rooms, physicians' offices and other health care environments in Europe and regions that recognize CE Mark. A portable, handheld blood analyzer, the i-STAT® uses two to three drops of a person's blood to perform common tests right at the bedside. By providing and transmitting test results within minutes to a patient's electronic medical records (EMR), the wireless device provides information to help enable clinicians to make important medical decisions quickly and accurately.

Abbot announces CE Mark for its handheld, wireless technology that provides...
Abbot announces CE Mark for its handheld, wireless technology that provides results at a patient’s bedside within minutes.
Source: Abbott Point of Care

"When it comes to clinical decision-making, time is critical," said Dr. Florian Falter, a consultant anesthetist at Papworth Hospital in Cambridge, United Kingdom. "Wireless point of care technology improves our team's ability to have fast access to blood test results and will help doctors act quickly to determine the best course of treatment. Being able to act without much delay is especially important in high-risk and intense situations."

For patients experiencing acute events that need rapid response, like chest pain, doctors and nurses can use the i-STAT® 1 Wireless System to perform a cardiac blood test, which helps detect a protein (troponin) associated with heart injury to determine if a person is having a heart attack. Abbott's technology transmits the test results for rapid review by a physician, which is particularly important in emergent situations.

In busy health care environments, the speed of the i-STAT® 1 Wireless System can improve efficiencies for clinicians and their health care systems by simplifying the testing process. Additionally, as electronic medical records are being introduced more widely as standard practice, the wireless i-STAT® can also automatically transfer a patient’s results, replacing manual entry of results and reducing the risk of human error. This means there may be savings from a time, cost and a staff resource perspective, allowing clinicians to focus directly on patient care.

"Abbott's i-STAT® point of care testing system is already being used successfully in hospitals and in other medical environments across Europe," said Luc Ruysen, divisional vice president, international commercial operations, Point of Care, Abbott. "We look forward to having the new wireless capability further increase the use of the technology and offer clinicians a tool to help increase efficiency, reduce costs and improve care."

About Abbott Point of Care:

Abbott Point of Care is headquartered in Princeton, N.J., and develops, manufactures and markets critical medical diagnostic and data management products for rapid blood analysis. The company's premier product is the i-STAT® System, a handheld device capable of performing a broad menu of tests, including cardiac markers; blood gases; coagulation; lactate; chemistries/electrolytes; and hematology, using two or three drops of blood at the patient's side.

Source: Abbott Point of Care

19.05.2015

Read all latest stories

Related articles

Photo

News • Deadly heart inflammation

Hope for first blood test to detect myocarditis

The first blood test to diagnose inflammation of the heart muscle (myocarditis) could be in use in as little as a year, following the discovery of a molecular signal in the blood.

Photo

Article • Hypertension and CVD assessment and prediction

Blood pressure measurement: deceivingly simple, yet highly complex

Blood pressure is one of the most basic parameters in any healthcare status assessment and holds considerable diagnostic significance. However, clinicians should never underestimate the complexity…

Photo

News • Liquid biopsy for early detection of brain tumours

Glioblastoma: Mathematical modelling could lead to simple blood test

The development of a simple blood test for glioblastomas could mean earlier diagnosis and more effective and personalised treatment options against the most common type of malignant brain cancer.

Related products

KABE Labortechnik – Consumables for blood gas analysis

Blood Gases /Electrolytes /Oximetry

KABE Labortechnik – Consumables for blood gas analysis

KABE LABORTECHNIK GmbH
KABE Labortechnik – Consumables for pathology / histology

Histology Equipment

KABE Labortechnik – Consumables for pathology / histology

KABE LABORTECHNIK GmbH
KABE Labortechnik – Pipette-Adapter for Capillaries (PAC)

Blood Gases, Electrolytes, Oximetry

KABE Labortechnik – Pipette-Adapter for Capillaries (PAC)

KABE LABORTECHNIK GmbH
Nova Biomedical – EMS Stat*

Other

Nova Biomedical – EMS Stat*

Nova Biomedical Corporation
Subscribe to Newsletter